Latest News

Halting immune response could save brain cells after stroke

A new study in animals shows that using a compound to block the body?s immune response greatly reduces disability after a stroke. The study also showed that particular immune cells -- CD4+ T-cells produce a mediator, called interleukin (IL) -21 that can cause further damage in stroke tissue. Moreover, normal mice, ordinarily killed or disabled by an ischemic stroke, were given a shot of a compound that blocks the action of IL-21. Brain scans and brain sections showed that the treated mice suffered little or no stroke damage.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Early prosocial behavior good predictor of kids' future

  • Science educators analyze genetics content of Next Generation Science Standards

  • Study of 'senior citizen' marine snails uncovered how nerve cells fail during learning

  • Targeted therapy shows effectiveness against a subtype of the brain tumor medulloblastoma

  • Naturally occurring protein fragment found in the brain inhibits key enzyme implicated in Alzheimer's disease

  • Ongoing recovery efforts take toll on hurricane survivors

  • Climbing a tree can improve cognitive skills, researchers say

  • Socially integrated women have lower suicide risk

  • Key factor for stability of capillaries in brain identified

  • Mechanism behind the lack of effectiveness of certain antagonist drugs discovered

  •